'Entresto' Patent Claims Are Obvious, Petitioner Tells Patent Board
ALEXANDRIA, Va. — A claimed pharmaceutical composition for the treatment of hypertension, as embodied in the drug "Entresto," is unpatentable as obvious, a petitioner tells the Patent Trial and Appeal Board...To view the full article, register now.
Already a subscriber? Click here to view full article